Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial)
- 1 February 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (4) , 529-532
- https://doi.org/10.1016/j.amjcard.2004.10.026
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failureEuropean Heart Journal, 2003
- Sustained Reduction of Aldosterone in Response to the Angiotensin Receptor Blocker Valsartan in Patients With Chronic Heart FailureCirculation, 2003
- Effects of Valsartan on Circulating Brain Natriuretic Peptide and Norepinephrine in Symptomatic Chronic Heart FailureCirculation, 2002
- Long-Term Trends in the Incidence of and Survival with Heart FailureNew England Journal of Medicine, 2002
- Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic studyJournal of the American College of Cardiology, 2002
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Baseline demographics of the Valsartan Heart Failure TrialEuropean Journal of Heart Failure, 2000
- Comparison of one-year outcome in women versus men with chronic congestive heart failureThe American Journal of Cardiology, 2000
- Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failureJournal of Cardiac Failure, 1999
- Congestive heart failure in patients with coronary artery disease: The gender paradoxAmerican Heart Journal, 1997